Bank of New York Mellon’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $247K | Hold |
|
|||||
|
2022
Q4 | $148K | Sell |
|
|||||
|
2022
Q3 | $339K | Buy |
|
|||||
|
2022
Q2 | $383K | Sell |
|
|||||
|
2022
Q1 | $865K | Buy |
|
|||||
|
2021
Q4 | $1.06M | Sell |
|
|||||
|
2021
Q3 | $952K | Buy |
|
|||||
|
2021
Q2 | $695K | Buy |
|
|||||
|
2021
Q1 | $731K | Sell |
|
|||||
|
2020
Q4 | $504K | Sell |
|
|||||
|
2020
Q3 | $1.52M | Sell |
|
|||||
|
2020
Q2 | $1.39M | Sell |
|
|||||
|
2020
Q1 | $993K | Sell |
|
|||||
|
2019
Q4 | $1.92M | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $421K | Buy |
|
|||||
|
2019
Q1 | $420K | Sell |
|
|||||
|
2018
Q4 | $233K | Buy |
|
|||||
|
2018
Q3 | $309K | Buy |
|
|||||
|
2018
Q2 | $365K | Sell |
|
|||||
|
2018
Q1 | $1.09M | Buy |
|
|||||
|
2017
Q4 | $585K | Buy |
|
|||||
|
2017
Q3 | $646K | Buy |
|
|||||
|
2017
Q2 | $359K | Buy |
|
|||||
|
2017
Q1 | $385K | Buy |
|